Long-Term Results of IFRT vs. ISRT in Infradiaphragmal Fields in Aggressive Non-Hodgkins’s Lymphoma Patients—A Single Centre Experience
(1) Background: This study aimed to examine the difference in efficacy and toxicity of involved-field (IFRT) and involved-site radiotherapy (ISRT) fields in infradiaphragmal aggressive non-Hodgkin lymphoma patients. (2) Methods: In total, 140 patients with infradiaphragmal lymphoma treated between 2...
Main Authors: | Lea Galunic Bilic, Fedor Santek, Zdravko Mitrovic, Sandra Basic-Kinda, Dino Dujmovic, Marijo Vodanovic, Inga Mandac Smoljanovic, Slobodanka Ostojic Kolonic, Ruzica Galunic Cicak, Igor Aurer |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2024-02-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/16/3/649 |
Similar Items
-
Infradiaphragmal Radiotherapy in Patients with Lymphoma: Volume Definition and Side Effects
by: Lea Galunić Bilić, et al.
Published: (2018-01-01) -
FLOW CYTOMETRY IN MYELODYSPLASTIC SYNDROME- CORRELATION WITH CYTOMORPHOLOGY RESULTS
by: I. Mandac Smoljanovic, et al.
Published: (2024-01-01) -
P016: Reduced steroid exposure is safe and does not reduce disease control among Hodgkin Lymphoma patients treated with escalated BEACOPP (eBEACOPP)
by: Ida Hude Dragičević, et al.
Published: (2022-10-01) -
Lenalidomide induced good clinical response in a patient with multiple relapsed and refractory Hodgkin's lymphoma
by: Kolonic Slobodanka, et al.
Published: (2010-05-01) -
Reduced Corticosteroid Exposure Is Safe and Does Not Reduce Disease Control among Hodgkin Lymphoma Patients Treated with Escalated BEACOPP (eBEACOPP)
by: Ida Hude Dragičević, et al.
Published: (2024-03-01)